Major Ingredients

(Chloramphenicol BP 5 mg + Dexamethasone phosphate USP 1 mg) /ml.

Major Functionality

For steroid-responsive inflammatory ocular condition for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. For inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. For chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.